July 25, 2008
3 min read
Save

Eye care experts call for stronger contact lens product testing, labeling

Speakers from optometry, ophthalmology and industry make recommendations to improve FDA contact lens guidelines.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A panel of eye care experts advising the U.S. Food and Drug Administration has recommended that the agency adopt stricter contact lens product testing and adapt standardized lens care guidelines for consumers.

Some of the specific recommendations, which were presented in Washington, D.C. in June, include a warning against reusing solutions, exposing contact lens cases and contact lenses to water, and not rubbing and rinsing lenses.

The panel agreed that a clear, stringent warning should be included on contact lens care products against reusing or “topping off” solutions.

“I think it should be a strong warning,” panel member William D. Mathers, MD, said. “Saying that you could get an eye infection is not a strong warning. Saying that you could go blind is a strong warning.”

The panel also advised against exposing lens cases to any types of water and conveying the risk of eye infection when a contact lens becomes exposed to water. It also recommended that rubbing and rinsing instructions should be included on product labeling, although panel members could not agree on a set amount of time.

“We don’t necessarily have the data right now to give a time,” panel member Neil M. Bressler, MD, said. “I presume that if everyone started rubbing and rinsing, that might be a step in the right direction.”

The panel also agreed that companies should test solutions against Acanthamoeba as a rule, as well as other bacteria and fungi.

These recommendations follow the voluntary recalls of contact lens solutions linked to keratitis outbreaks in 2006 and 2007, as well as reports that the number of microbial keratitis cases, namely cases of Acanthamoeba keratitis, remains steady among contact lens wearers, according to a joint press release from a coalition that includes the American Academy of Ophthalmology, the Contact Lens Association of Ophthalmologists, the Cornea Society and the American Society of Cataract and Refractive Surgery.

Elmer Y. Tu, MD, director of the cornea and external disease service at the University of Illinois at Chicago, spoke on behalf of that consortium during the open public hearing session. He addressed the panel concerning contact lens disinfection systems and recommendations for preclinical testing and development.

“Experts agree that the rates of microbial keratitis, in general, have not substantially declined, despite the evolution of contact lens disinfection systems over the past 2 decades,” Dr. Tu said.

He recommended that the FDA require a discard date on all contact lens care products, in addition to the expiration date, and the panel later agreed to suggest that to the FDA.

J. James Thimons, OD, of Ophthalmic Consultants of Connecticut, spoke to the panel about corneal staining and its role in predicting the best combinations of solutions and contact lenses.

“No single element is capable of defining the risk that our patients undergo,” Dr. Thimons said. “There is minimal evidence about the correlation between staining and eventual microbial infection or damage due to multipurpose solution. My recommendation to the committee would be that we develop a collaborative effort on the part of industry, the FDA and clinicians to define this material at a better and more useful level.”

The panel said there was not enough information about the practice of staining to endorse a recommendation.

The FDA is currently reviewing the safety and effectiveness of contact lens and lens care products already on the market, and it is expected to endorse the panel’s recommendations.

A complete list of all of the recommendations made to the FDA about preclinical product testing and consumer lens care guidelines can be found at www.aao.org.

For more information:

  • William D. Mathers, MD, can be reached at Casey Eye Institute, 3375 SW Terwilliger Blvd., Portland, OR 97239-4197; 503-494-7674; fax: 503-494-3929; e-mail: mathersw@ohsu.edu.
  • Neil M. Bressler, MD, can be reached at Department of Ophthalmology, Wilmer Eye Institute, 550 N. Broadway, Suite 115, Baltimore, MD 21205-2002; 410-955-8342; e-mail: nmboffice@jhmi.edu.
  • Elmer Y. Tu, MD, can be reached at University of Illinois Eye and Ear Infirmary Department of Ophthalmology, 1855 W. Taylor St., Chicago, IL 60612; 312-355-4248; e-mail: etu@uic.edu.
  • J. James Thimons, OD, can be reached at Ophthalmic Consultants of Connecticut, 75 Kings Highway Cutoff, Fairfield, CT 06430; 203-257-7336; fax: 203-330-4958; e-mail: jthimons@sbcglobal.net.
  • Jena Passut is an OSN Correspondent who writes primarily for Primary Care Optometry News.
  • Joseph Master is the Online Content Editor of the OSN Supersite.